Advertisement
Advertisement
AVIR
Atea Pharmaceuticals, Inc. Common Stock
5.83
USDSponsored
+0.01
+0.17%
Sep 04, 15:59 UTC -4
Closed
After-Market
5.87
+0.04
+0.69%
AVIR Earnings Reports
Positive Surprise Ratio
AVIR beat 17 of 24 last estimates.
71%
Next Report
Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$0.42
Implied change from Q2 26 (Revenue/ EPS)
--
/+2.44%
Implied change from Q3 25 (Revenue/ EPS)
--
/-20.75%
Atea Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On Aug 12, 2026, AVIR reported earnings of -0.41 USD per share (EPS) for Q2 26, beating the estimate of -0.57 USD, resulting in a 28.22% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.20% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.42 USD, with revenue projected to reach -- USD, implying an increase of 2.44% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Clinuvel Pharmaceuticals Limited - ADR
Report Date
Aug 27, 2026 For Q4 26
Estimate
$0.50
Actual
-Surprise
-
Anavex Life Sciences
Report Date
Aug 25, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+1.96%
Molecular Partners AG - ADR
Report Date
Aug 25, 2026 For Q2 26
Estimate
-Actual
-$0.35
Surprise
-
FAQ
What were Atea Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Atea Pharmaceuticals, Inc. Common Stock reported EPS of -$0.41, beating estimates by 28.22%, and revenue of $0.00, 0% as expectations.
How did the market react to Atea Pharmaceuticals, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 0.2%, changed from $5.06 before the earnings release to $5.07 the day after.
When is Atea Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 10, 2026.
What are the forecasts for Atea Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 3
analysts, Atea Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.42 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement